3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Prolymphocytic
1
Leukemia, Plasma Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hematologic Diseases
1
Burkitt Lymphoma
1
Interventions
Cyclophosphamide
125
fludarabine phosphate
116
Busulfan
98
Peripheral Blood Stem Cell Transplantation
88
Filgrastim
73
Antilymphocyte Serum
72
Tacrolimus
67
Cytarabine
67
Cyclosporine
64
Mycophenolic Acid
63
Methotrexate
57
Radiotherapy
54
fludarabine
52
Whole-Body Irradiation
52
Melphalan
49
Imatinib Mesylate
41
Azacitidine
35
Methylprednisolone
34
Etoposide
33
Cord Blood Stem Cell Transplantation
30
Granulocyte Colony-Stimulating Factor
28
sargramostim
26
Thiotepa
26
Decitabine
21
Alemtuzumab
21
Clofarabine
20
thymoglobulin
19
Stem Cell Transplantation
19
nilotinib
18
Interferon-alpha
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
Association
×
Myeloid
×
Clear all
NCT06022016
2025-12-08
LUCID
Institut Claudius Regaud
Phase NA
Recruiting
910 enrolled